Your Notifications
All done, no notifications

Rhabdomyosarcoma (RMS) Treatment Cost in Jordan

Costs starts from USD10000 to USD25000
Filters

How Much Does Rhabdomyosarcoma (RMS) Treatment Cost in Jordan?

Depending on tumour type, stage, location, and the required combination of therapies, the cost of Rhabdomyosarcoma (RMS) treatment in Jordan typically ranges from USD 10000 - USD 25000. Factors such as disease complexity, the duration and intensity of chemotherapy, the use of advanced radiation techniques, and the expertise of paediatric or adult sarcoma specialists can significantly influence overall cost.

Additional expenses may include diagnostic biopsies, histopathology and molecular testing, imaging studies (MRI, CT, PET scans), chemotherapy drugs and supportive medications, radiation therapy planning and sessions, surgical hospitalisation charges, and post-treatment rehabilitation. In many cases, long-term follow-up, including surveillance imaging, blood tests, and management of treatment-related side effects, may be required, which can further increase the total treatment cost.

Factors Influencing the Cost of Rhabdomyosarcoma (RMS) Treatment

Cost of Rhabdomyosarcoma (RMS) Treatment in Major cities of Jordan

CityMinimum Cost (USD)Minimum Cost (JOD)Maximum Cost (USD)Maximum Cost (JOD)
AmmanUSD 100007100USD 2500017750

Rhabdomyosarcoma (RMS) Treatment Cost : A Global Comparison

CountryMinimum CostMinimum Local CurrencyMaximum CostMaximum Local Currency
JordanUSD 10000JOD 7100USD 25000JOD 17750
VietnamUSD 8000VND 207720000USD 20000VND 519300000

Need Help Planning Your Treatment Abroad?

Your 24/7 AI Health Assistant

Commonly affecting children and young adults, rhabdomyosarcoma (RMS) is an uncommon and aggressive form of soft tissue cancer that arises in skeletal muscle cells. Treatment for rhabdomyosarcoma (RMS) includes radiation therapy to stop recurrence, chemotherapy to reduce or eradicate cancer cells, and surgery to remove the tumor. In certain situations, immunotherapy or targeted therapy may be employed. Rehabilitation and pain management are supportive care that enhances a patient's quality of life.

Top Selling Packages for Rhabdomyosarcoma (RMS) Treatment

Rhabdomyosarcoma (RMS) Treatment
Rhabdomyosarcoma (RMS) Treatment

Global Health City, Chennai, India

USD 6500 USD 7500

Would you like some help? We are available.

Get Help
Explore Hospitals ( 1 )
Rhabdomyosarcoma (RMS) Treatment in Arab Medical Center: Costs, Top Doctors, and Reviews

Amman, Jordan

  • Joint Commission International, or JCI
  • The hospital offers specialised and high-quality medical care to both local and international patients.
  • It offers 24/7 emergency services with experienced staff and dedicated rooms for children and patients with infectious diseases.
  • AMC performs advanced surgeries, including those for the brain, heart, bones, and eyes.
  • The hospital has modern medical equipment and diagnostic tools for accurate testing and treatment.
  • It includes speciality clinics for heart, cancer, brain, diabetes, and more.
  • AMC supports critical care units like the Intensive Care Unit (ICU), Coronary Care Unit (CCU), and dialysis unit.
  • It ensures patient comfort through clean rooms, professional service, and luxury accommodation options.
  • The hospital promotes medical education and awareness through services like the Arabi Podcast.
  • AMC actively supports medical tourism and is known as a trusted referral hospital in the region.
  • It focuses on continuous quality improvement and compassionate care for every patient.
  • AMC has a loyalty program (Arabi Care Card) that offers benefits and discounts to regular patients.
  • The hospital ensures easy accessibility due to its central location near major landmarks and hotels in Amman.

Need Some Advice From Our Experts?

Request a Call Back Now!

Our team of healthcare experts would be happy to assist you

trusted Patientstrusted Patients+99
Trusted by 50000+ Patients
Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Instantly Connect with our Rhabdomyosarcoma (RMS) Treatment Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Other Popular Countries for Rhabdomyosarcoma (RMS) Treatment

Our network connects you with the leading medical tourism destinations globally, offering a wide range of cities, top doctors, and flexible pricing options.

United Kingdom
United Arab Emirates
Spain
Malaysia

Frequently Asked Questions

Rhabdomyosarcoma treatment is advised when a patient:
  • Is diagnosed with embryonal, alveolar, or pleomorphic rhabdomyosarcoma
  • Has a rapidly growing soft-tissue mass, often painful or causing functional impairment
  • Shows tumour spread to nearby tissues, lymph nodes, or distant organs
  • Experiences symptoms related to tumour location such as breathing difficulty, urinary obstruction, or vision problems
  • Has recurrent or progressive disease after initial therapy
  • Eligibility for treatment depends on tumour type, size, location, stage, patient age, overall health, and risk classification (low, intermediate, or high risk).

    Pre-Treatment:
  • Comprehensive oncological evaluation
  • Biopsy and histopathological confirmation
  • Immunohistochemistry and molecular testing
  • Imaging studies (MRI, CT scan, PET scan) to determine tumour extent
  • Bone marrow examination if metastasis is suspected
  • Assessment of organ function and treatment fitness
  • Treatment Approaches:Multimodal Therapy (Standard of Care):Surgery:
  • Tumour removal when anatomically feasible
  • Limb-sparing or organ-preserving techniques whenever possible
  • Chemotherapy:
  • Multi-agent chemotherapy to target microscopic and systemic disease
  • Given before surgery (neoadjuvant) or after surgery (adjuvant)
  • Radiation Therapy:
  • Used when complete surgical removal is not possible
  • Advanced techniques such as IMRT or proton therapy to minimise damage to healthy tissue
  • Duration:
  • Chemotherapy and radiation may continue for several months
  • Treatment duration varies based on risk category and response
  • Potential risks depend on the treatment modality and may include:
  • Chemotherapy-related side effects (nausea, fatigue, hair loss, infections)
  • Radiation-related tissue damage or growth disturbances (in children)
  • Surgical risks such as bleeding, infection, or functional impairment
  • Long-term effects, including fertility issues or organ dysfunction
  • Close monitoring helps reduce complications and improve long-term outcomes.
  • One of the leading hospitals in Jordan is:Arab Medical Center, Amman
  • Experienced paediatric and adult oncologists
  • Advanced imaging and radiation therapy facilities
  • Multidisciplinary sarcoma tumour boards
  • Comprehensive supportive care and long-term follow-up programs
  • Hospital stay: Varies based on surgery and chemotherapy cycles
  • Chemotherapy: Administered in cycles over several months
  • Radiation therapy: Typically delivered over 4-6 weeks
  • Functional recovery: Gradual, depending on tumour location and treatment intensity
  • Long-term follow-up is essential to monitor recurrence, growth, and late effects of therapy.

    Additional expenses may include:
  • Diagnostic biopsies and molecular testing
  • Imaging studies and staging scans
  • Chemotherapy drugs and supportive medications
  • Radiation therapy planning and sessions
  • Rehabilitation, physiotherapy, or psychological support
  • Follow-up visits and long-term surveillance
  • Amman is the preferred destination due to:
  • Availability of specialised paediatric and adult oncology centres
  • Advanced sarcoma treatment infrastructure
  • Multidisciplinary cancer care teams
  • Access to long-term survivorship and follow-up care
  • Experienced oncologists specialising in rare soft-tissue sarcomas
  • Modern chemotherapy, surgical, and radiation technologies
  • Patient-centred, multidisciplinary cancer care
  • Cost-effective treatment compared to many Western countries
  • Strong international patient support and care coordination
  • High survival rates for low-risk and early-stage RMS
  • Improved disease control with risk-adapted multimodal therapy
  • Better long-term outcomes with early diagnosis and complete treatment
  • Quality of life improves with comprehensive rehabilitation and follow-up
  • Author

    Dr. Vijita Jayan

    BPT, MPT (Neuro)

    18 Years of Experience

    With over 18 years of distinguished clinical experience, Dr. Vijita Jayan is a highly accomplished Clinical Director and Rehabilitation Specialist, renowned for her expertise in neuro-rehabilitation, functional recovery, and mobility-dependent case management. Her extensive practical knowledge enables her to design and implement individualized, evidence-based rehabilitation protocols that consistently yield measurable patient outcomes. A prolific researcher and academic writer, she has authored numerous peer-reviewed articles and research papers, significantly advancing the field of rehabilitative medicine. The recipient of multiple prestigious accolades, Dr. Jayan is widely regarded as one of the foremost authorities in Physical Medicine and Rehabilitation, continually shaping neuro-rehabilitative care through research, innovation, and clinical excellence.. View More

    Reviewer

    Dr Prateek Varshney

    Surgical Oncologist

    15 Years of Experience

    Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More